CONDENSED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
Mar. 31, 2025	Mar. 31, 2024
Income Statement [Abstract]
Royalty revenues	$ 109	$ 205
Costs and expenses:
Research and development	10,477	8,008
Selling, general and administrative	4,014	3,130
Total operating expenses	14,491	11,138
Loss from operations	(14,382)	(10,933)
Other income (expense), net:
Interest income, net	941	926
Other income (expense), net	7	(4)
Total other income (expense), net	948	922
Net loss	(13,434)	(10,011)
Preferred stock dividend payable on Series A Convertible Preferred Stock	(6)	(6)
Net loss attributable to common stockholders	$ (13,440)	$ (10,017)
Net loss per common share - basic	$ (0.2)	$ (0.22)
Net loss per common share - diluted	$ (0.2)	$ (0.22)
Weighted-average shares outstanding - basic	66,524	44,678
Weighted-average shares outstanding - diluted	66,524	44,678

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

Name:	us-gaap_EarningsPerShareBasic
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.